The nuclear bile acid receptor FXR as a novel therapeutic target in cholestatic liver diseases: Hype or hope?
Michael TraunerVolume:
40
Year:
2004
Language:
english
Pages:
4
DOI:
10.1002/hep.20294
File:
PDF, 216 KB
english, 2004